SAMDaily.us | MOD | A | Establishment of high throughput SARS-CoV-2 neutralizing antibody immunoassay capability and testing of human serum samples

SAMDAILY.US - ISSUE OF OCTOBER 29, 2020 SAM #6909
MODIFICATION

A -- Establishment of high throughput SARS-CoV-2 neutralizing antibody immunoassay capability and testing of human serum samples

Notice Date: 10/27/2020 9:31:08 AM
Notice Type: Justification
NAICS: 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Contracting Office: OFFICE OF ACQ MGMT POLICY WASHINGTON DC 20201 USA
ZIP Code: 20201
Solicitation Number: 75A50120R00053
Archive Date: 11/26/2020
Point of Contact: Rosa Lopez, Phone: 2025954991
E-Mail Address: Rosa.Lopez@hhs.gov
(Rosa.Lopez@hhs.gov)
Award Number: 75A50121P00002
Award Date: 10/26/2020
Description: The Biomedical Advanced Research and Development Authority (BARDA), Department of Health and Human Services (HHS) seeks to establish a high throughput SARS-CoV-2 high throughput SARS-CoV-2 neutralizing antibody immunoassay capability and testing of human serum samples. �
Web Link: SAM.gov Permalink
(https://beta.sam.gov/opp/b3160ebec56147d1a56a3cffee3d5c2a/view)
Place of Performance: Address: Columbus, OH 43201, USA; Zip Code: 43201; Country: USA
Record: SN05838631-F 20201029/201027230143 (samdaily.us)
Source: SAM.gov Link to This Notice
(may not be valid after Archive Date)

| FSG Index | This Issue's Index | Today's SAM Daily Index Page |